Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Energy Fuels
UUUU
$2.86B
| $138K | ﹤0.01% |
71,302
+10,612
| +17% | +$21.2K |
|
|
QVCGA
5127
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $138K | ﹤0.01% |
276
+225
| +441% | +$132K |
|
|
CHU
5128
CALL
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $138K | ﹤0.01% |
+13,200
| New | +$134K |
|
|
EEX
5129
DELISTED
Emerald Holding
EEX
| $137K | ﹤0.01% |
14,074
-3,701
| -21% | -$37.8K |
|
5130
Lifecore Biomedical
LFCR
$166M
| $137K | ﹤0.01% |
12,514
-3,748
| -23% | -$40.8K |
|
5131
NWPX Infrastructure Inc
NWPX
$1.19B
| $137K | ﹤0.01% |
4,870
-1,496
| -23% | -$38.1K |
|
|
MCBC
5132
DELISTED
Macatawa Bank Corp
MCBC
| $137K | ﹤0.01% |
13,234
-4,071
| -24% | -$41.4K |
|
|
MGLN
5133
PUT
DELISTED
Magellan Health Services, Inc.
MGLN
| $137K | ﹤0.01% |
+2,200
| New | +$147K |
|
5134
Bridgewater Bancshares
BWB
$571M
| $136K | ﹤0.01% |
11,341
-4,178
| -27% | -$48.5K |
|
5135
PUT
Cameco
CCJ
$37.6B
| $136K | ﹤0.01% |
14,300
-800
| -5% | -$7.51K |
|
5136
Clarus
CLAR
$123M
| $136K | ﹤0.01% |
11,691
-3,681
| -24% | -$45.6K |
|
|
EBTC
5137
DELISTED
Enterprise Bancorp
EBTC
| $136K | ﹤0.01% |
4,551
-1,717
| -27% | -$50.6K |
|
5138
ProShares Ultra Real Estate
URE
$57.8M
| $136K | ﹤0.01% |
1,560
| – | – |
|
5139
CALL
US Foods
USFD
$22.2B
| $136K | ﹤0.01% |
3,300
| – | – |
|
5140
PUT
United Therapeutics
UTHR
$25.8B
| $136K | ﹤0.01% |
1,700
-1,700
| -50% | -$137K |
|
5141
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $136K | ﹤0.01% |
900
+700
| +350% | +$106K |
|
|
WAAS
5142
DELISTED
AquaVenture Holdings Limited
WAAS
| $136K | ﹤0.01% |
6,994
-830
| -11% | -$15.1K |
|
5143
PUT
CoreCivic
CXW
$2.96B
| $135K | ﹤0.01% |
7,800
+4,600
| +144% | +$80.9K |
|
5144
ProShares Ultra Energy
DIG
$82.8M
| $135K | ﹤0.01% |
4,554
+4,400
| +2,857% | +$137K |
|
5145
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.34B
| $135K | ﹤0.01% |
1,839
-1,643
| -47% | -$119K |
|
5146
PUT
Fossil Group
FOSL
$293M
| $135K | ﹤0.01% |
10,800
-19,400
| -64% | -$220K |
|
5147
Northrim BanCorp
NRIM
$590M
| $135K | ﹤0.01% |
13,524
-4,460
| -25% | -$41.5K |
|
5148
SmartFinancial
SMBK
$896M
| $135K | ﹤0.01% |
6,458
-2,008
| -24% | -$42.3K |
|
5149
CALL
Xylem
XYL
$27.3B
| $135K | ﹤0.01% |
1,700
+400
| +31% | +$31.4K |
|
|
XONE
5150
PUT
DELISTED
The ExOne Company
XONE
| $135K | ﹤0.01% |
15,300
+2,500
| +20% | +$20.4K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.